CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF ADAMANTANE DERIVATIVE IN THERAPY OF ASTHENIC DISORDERS IN EARLY FORMS OF CHRONIC BRAIN ISCHEMIA
https://doi.org/10.15789/1563-0625-2017-4-441-452
Abstract
A non-specific stress-induced overload of limbic-reticular emotiogenic structures under the deficiency conditions of endogenous energy resources is the main mechanism for development of asthenic disorders with early developing chronic brain ischemia among veterans of recent wars, upon their return to civilian life. We observed a group of 30 Afghan veterans with early forms of chronic brain ischemia and manifestations of psychogenic asthenic syndrome. When treating psychogenic asthenic syndrome in the veterans of recent military conflicts, an adamantane derivative administered as a course treatment, at a dose of 50 mg 2 times daily causes psychostimulant, anxiolytic, vegetotropic, antihypotymic, and hypnotic pharmacological effects, with reduction of main psychopathological and somatoneurological symptoms.
A notable immunotropic effect of the drug was revealed, being expressed as enhanced immunopoiesis; activation of innate defense mechanisms; expansion of Treg lymphocyte population, suggestive for increased suppressor effect upon the mechanisms of autoimmune aggression; implementation of cell differentiation/ proliferative effect; anti-apoptogenic properties; anti-inflammatory activity (reduction of TNFα, IL-8, hsCRP, along with IL-2 increase) associated with reduced functional activity of mononuclear cells; vasotropic action expressed as normalized balance of vasoactive factors (nitric oxide, endothelin-1), decrease of nitrotyrosine concentration, suggesting the nitrosylation stress reduction. The actoprotective drug effect is implemented due to a combined psychostimulant, vasotropic, proliferative effects. It may be expressed in terms of higher efficiency and optimization of systemic hemodynamic parameters.
About the Authors
E. V. Davydova
South Ural State Medical University
Russian Federation
Russian Federation
Davydova Evgenia V. - PhD (Medicine), Associate Professor, Department of Pathophysiology.
454092, Chelyabinsk, Vorovskogo str., 64. Phone: 7 (908) 060-92-06
A. V. Zurochka
Research Institute of Immunology and Physiology; South Ural State University (National Research University)
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, Leading Research Associate, RIIP.
Ekaterinburg, ChelyabinskReferences
1. Аведисова А.С. Антиастенические препараты как терапия первого выбора при астенических расстройствах // Русский медицинский журнал, 2004. Т. 12, № 22. С. 1290. [Avedisova A.S. Anti-asthenic drugs as a first-line therapy in asthenic disorders. Russkiy meditsinskiy zhurnal = Russian Medical Journal, 2004, Vol. 12, no. 22, p. 1290. (In Russ.)]
2. Булатова Г.Р., Новикова Л.Б., Науширванов О.Р., Нигматуллин Р.Х. Характеристика психовегетативного синдрома и его медикаментозная коррекция у сотрудников правоохранительных органов // Вестник современной клинической медицины, 2015. Т. 8. № 6. С. 9-14. [Bulatova G.R., Novikova L.B., Naushirvanov O.R., Nigmatullin R.Kh. Characteristics of psycho-vegetative syndrome and drug correction of law enforcement officers. Vestnik sovremennoy klinicheskoy meditsiny = Journal of Modern Clinical Medicine, 2015, Vol. 8, no. 6, pp. 9-14. (In Russ.)]
3. Вахитова Ю.В., Садовников C.B., Ямиданов P.C., Середенин С.Б. Деметилирование остатков цитозина в промоторной области гена тирозингидроксилазы в клетках головного мозга крыс под действием производного аминоадамантана – ладастена // Генетика, 2006. Т. 42, № 7. С. 968-975. [Vakhitova Yu.V., Sadovnikov S.V., Yamidanov R.S., Seredenin S.B. De-methylation of cytosine residues in the tyrosine hydroxylase promoter region of the gene in brain cells of rats under the action of aminoadamantane derivative – Ladasten. Genetika = Genetics, 2006, Vol. 42, no. 7, pp. 968-975. (In Russ.)]
4. Вахитова Ю.В., Ямиданов Р.С., Середенин С.Б. Ладастен индуцирует экспрессию генов, регулирующих биосинтез дофамина в различныз структурах мозга крыс // Экспериментальная и клиническая фармакология, 2004. Т. 67, № 4. C. 7-11. [Vakhitova Yu.V., Yamidanov R.S., Seredenin S.B. Ladasten induces the expression of genes governing the biosynthesis of dopamine in various structures of rat brain. Eksperimentalnaya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology, 2004, Vol. 67, no. 4, pp. 7-11. (In Russ.)]
5. Незнамов Г.Г., Сюняков С.А., Гришин С.А., Телешова Е.С., Бочкарев В.К., Ларкова М.А, Середенин С.Б. Ладастен – перспективное средство коррекции астенических нарушений, развивающихся в экстремальных условиях // Симпозиум, посвященный 75-летию ГосНИИИ ВМ «Боевой стресс: механизмы стресса в экстремальных условиях». М., 2005. С. 142-144. [Neznamov G.G., Syunyakov S.A., Grishin S.A., Teleshova E.S., Bochkarev V.K., Larkova M.A., Seredenin S.B. Ladasten – a promising means of correction of asthenic disorders developing in extreme conditions. Symposium dedicated to the 75th anniversary of the Research Institute of the VM «Combat stress: mechanisms of stress in extreme conditions.»]. Moscow, 2005, pp. 142-144.
6. Сибиряк C.B., Курчатова H.H., Юсупова Р.Ш., Сибиряк Д.С., Ахматова Н.К., Бикмаева А.Р., Вахитова Ю.В. Оценка индуцированного анти-СDЗмАт митогенеза и активности каспазы С, как способ характеристики реактивности Т-лимфоцитов в клинических и экспериментальных исследованиях // Россий иммунологический журнал, 2002. Т. 7, № 3. С. 265-267. [Sibiryak S.V., Kurchatova N.N., Yusupova R.Sh., Sibiryak D.S., Akhmatova N.K., Bikmaeva A.R., Vakhitova Yu.V. Evaluation of induced anti-SDZmAt mitogenesis and caspase C as a means of characterizing the reactivity of T lymphocytes in clinical and experimental studies. Rossiyskiy immunologicheskiy zhurnal = Russian Immunological Journal, 2002, Vol. 7, no. 3, pp. 265-267. (In Russ.)]
7. Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга // Журнал невропатологии и психиатрии, 1985. № 9. С. 1281-1288. [Schmidt E.V. Classification of vascular lesions of the brain and spinal cord. Zhurnal nevropatologii i psikhiatrii = Journal of Neuropathology and Psychiatry, 1985, no. 9, pp. 1281-1288. (In Russ.)]
8. Naoki Otani, Hiroshi Nawashiro, Kimihiro Nagatani, Satoru Takeuchi, Hiroaki Kobayashi, Katsuji Shima. Mitogen-Activated Protein Kinase Pathways Following Traumatic Brain Injury. Neuroscience and Medicine, 2001, Vol. 2, no. 3, pp. 208-216.
9. Zaunders J.J., Dyer W.B., Munier M.L., Ip S., Liu J., Amyes E., Rawlinson W., De Rose R., Kent S.J., Sullivan J.S., Cooper D.A., Kelleher A.D. CD127+CCR5+CD38+++CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells. J. Virol., 2006, Vol. 80, no. 20, pp. 10151-10161.
Review
For citations:
Davydova E.V., Zurochka A.V. CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF ADAMANTANE DERIVATIVE IN THERAPY OF ASTHENIC DISORDERS IN EARLY FORMS OF CHRONIC BRAIN ISCHEMIA. Medical Immunology (Russia). 2017;19(4):441-452. (In Russ.) https://doi.org/10.15789/1563-0625-2017-4-441-452
Views:
952
Email this article 